期刊文献+

Effects of estrogen replacement therapy on apoptosis and vascular endothelial growth factor expression in ocular surface epithelial cells:An experimental study 被引量:8

Effects of estrogen replacement therapy on apoptosis and vascular endothelial growth factor expression in ocular surface epithelial cells:An experimental study
原文传递
导出
摘要 AIM:To investigate the effects of estrogen replacement therapy (ERT) on apoptosis and vascular endothelial growth factor (VEGF) expression in ocular surface in an experimental rat model.· METHODS:Forty female,Wistar rats were randomized in 4 groups in the study.Subcutaneous ERT (17β-estradiol,10g/kg/day) was administered to the first group without ovariectomy and to the second group with ovariectomy for three months.Third group had only ovariectomy and fourth group had sham operation.All rats were sacrificed in estrous cycles determined by vaginal smear test and their right eyes were enucleated at the end of the third month.Enucleated eyes were analyzed by immunohistochemical method for expressions of caspase-3,bcl-2,VEGF and TUNEL assay.· RESULTS:Caspase-3 expression of conjunctival epithelium was significantly higher in group 3 than group 1 (P =0.005),and group 2 (P =0.007).TUNEL score of conjunctival epithelium was significantly higher in group 3 than group 1 (P =0.006).TUNEL score of corneal epithelium was significantly higher in group 3 than group 2 (P =0.012),and group 4 (P =0.002).There was no significant difference between groups in that bcl-2 and VEGF expressions.· CONCLUSION:We determined increased apoptosis in ocular surface epithelial cells in ovariectomized rats.ERT and endogen estrogen decreased the apoptosis,and did not result in difference in VEGF expression between the groups.Estrogen may be beneficial for the treatment of apoptosis-mediated ocular surface disorders such as dry eye.Further studies are needed on this subject for a better understanding of the role of estrogen and to provide a new insight for treatment and prevention of apoptosis-mediated ocular surface disorders. AIM:To investigate the effects of estrogen replacement therapy (ERT) on apoptosis and vascular endothelial growth factor (VEGF) expression in ocular surface in an experimental rat model.· METHODS:Forty female,Wistar rats were randomized in 4 groups in the study.Subcutaneous ERT (17β-estradiol,10g/kg/day) was administered to the first group without ovariectomy and to the second group with ovariectomy for three months.Third group had only ovariectomy and fourth group had sham operation.All rats were sacrificed in estrous cycles determined by vaginal smear test and their right eyes were enucleated at the end of the third month.Enucleated eyes were analyzed by immunohistochemical method for expressions of caspase-3,bcl-2,VEGF and TUNEL assay.· RESULTS:Caspase-3 expression of conjunctival epithelium was significantly higher in group 3 than group 1 (P =0.005),and group 2 (P =0.007).TUNEL score of conjunctival epithelium was significantly higher in group 3 than group 1 (P =0.006).TUNEL score of corneal epithelium was significantly higher in group 3 than group 2 (P =0.012),and group 4 (P =0.002).There was no significant difference between groups in that bcl-2 and VEGF expressions.· CONCLUSION:We determined increased apoptosis in ocular surface epithelial cells in ovariectomized rats.ERT and endogen estrogen decreased the apoptosis,and did not result in difference in VEGF expression between the groups.Estrogen may be beneficial for the treatment of apoptosis-mediated ocular surface disorders such as dry eye.Further studies are needed on this subject for a better understanding of the role of estrogen and to provide a new insight for treatment and prevention of apoptosis-mediated ocular surface disorders.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2012年第1期64-68,共5页 国际眼科杂志(英文版)
基金 Supported by the Research Fund of Adnan Menderes University,Aydin,Turkey
关键词 APOPTOSIS CONJUNCTIVA CORNEA ESTROGEN ocular surface vascular endothelial growth factor apoptosis conjunctiva cornea estrogen ocular surface vascular endothelial growth factor
  • 相关文献

参考文献43

  • 1何燕玲,黎晓新,鲍永珍,孙建民,刘金荣.雌激素受体基因多态性与绝经后干眼症的相关性的研究[J].眼科学报,2006,22(4):233-236. 被引量:12
  • 2Fatih ?zcura,Sema Oru? Dündar,Emel Dikicio?lu ?etin,Nahit Beder,Mehmet Dündar.Effect of estrogen replacement therapy on lens epithelial cell apoptosis in an experimental rat model[J]. International Ophthalmology . 2010 (3)
  • 3Felix Bock,Yanyan K?nig,Friedrich Kruse,Martin Baier,Claus Cursiefen.Bevacizumab (Avastin) eye drops inhibit corneal neovascularization[J]. Graefe’s Archive for Clinical and Experimental Ophthalmology . 2008 (2)
  • 4C. Huber,S. Collishaw,J. R. Mosley,J. Reeve,B. S. Noble.Selective Estrogen Receptor Modulator Inhibits Osteocyte Apoptosis during Abrupt Estrogen Withdrawal: Implications for Bone Quality Maintenance[J]. Calcified Tissue International . 2007 (2)
  • 5Jinghua Sun,Jingxin Wang.Cyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epithelium[J]. Journal of Huazhong University of Science and Technology . 2006 (4)
  • 6Stina Garvin,Ulrika W. Nilsson,Fredrik R. M. Huss,Gunnar Kratz,Charlotta Dabrosin.Estradiol increases VEGF in human breast studied by whole-tissue culture[J]. Cell and Tissue Research . 2006 (2)
  • 7Stern ME,Gao J,Siemasko KF,Beuerman RW,Pflugfelder SC al.The role of the lacrimal functional unit in the pathophysiology of dry eye. Experimental Eye Research . 2004
  • 8Nelson LM,Covington SN,Rebar RW.An update:spontaneous premature ovarian failure is not an early menopause. Fertility and Sterility . 2005
  • 9Schaumberg DA,Buring JE,Sullivan DA,Dana MR.Hormone replacement therapy and dry eye syndrome. The Journal of The American Medical Association . 2001
  • 10Pelit A,BagiST,Kayaseluk F,Dursun D,Akova Y,Aydin P.Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women. European Journal of Ophthalmology . 2003

二级参考文献14

  • 1[1]Lange C,Fernandez J,Shim D,et al.Mucin gene expression is not regulated by estrogen and/or progesterone in the ocular surface epithelia of mice.Exp Eye Res,2003;77(1):59-68.
  • 2[2]Marcozzi G,Liberati V,Madia F,et al.Age-and genderrelated differences in human lacrimal fluid peroxidase activity.Ophthalmologica,2003;217(4):294-297.
  • 3[3]Han KO,Moon IG,Kang YS,et al.Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women.J Clin Endocrinol Metab,1997; 82(4):991-995.
  • 4[5]Beauregard C,Brandt P.Down regulation of interleukin-1 beta-induced nitric oxide production in lacrimal gland acinar cells by sex steroids.Curr Eye Res,2004;29(1):59-66.
  • 5[6]Pelit A,Bagis T,Kayaselcuk F,et al.Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women.Eur J Ophthalmol,2003; 13(4):337-342.
  • 6[7]Lang Y,Lang N,Ben-Ami M,et al.The effects of hormone replacement therapy (HRT) on the human eye.Harefuah,2002;141(3):287-291.
  • 7[8]Scott G,Yiu SC,Wasilewski D,et al.Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women.Am J Ophthalmol,2005;139(6):1109-1110.
  • 8[9]Schaumberg DA,Buring JE,Sullivan MR,et al.Hormone replacement therapy and dry eye syndrome.JAMA,2001;286(17):2114-2119.
  • 9[10]Esmaeli B,Harvey JT,Hewlett B.Immunohistochemical evidence for estrogen receptors in meibomian glands.Ophthalmology,2000;107(1):180-184.
  • 10[11]Vécsei PV,Kircher K,Kaminski S,et al.Immunohistochemical detection of estrogen and progesterone receptor in human cornea.Maturitas,2000; 36(3):169-172.

共引文献15

同被引文献70

引证文献8

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部